2024-05-03 |
2024-05-02 |
V
Vente
|
Crombez Eric
EVP and Chief Medical Officer
Dirigeant
|
354
-0.7%
43,66
15 456
USD
|
354
-0.7%
|
43,66
|
15 456
USD
|
|
2024-04-19 |
2024-04-18 |
V
Vente
|
Crombez Eric
EVP and Chief Medical Officer
Dirigeant
|
142
-0.3%
44,10
6 262
USD
|
142
-0.3%
|
44,10
|
6 262
USD
|
|
2024-03-12 |
2024-03-11 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
11 509
-4.4%
49,93
574 644
USD
|
11 509
-4.4%
|
49,93
|
574 644
USD
|
|
2024-03-11 |
2024-03-07 |
V
Vente
|
Fust Matthew K
Administrateur non-exécutif
|
7 500
-33.5%
50,88
381 600
USD
|
7 500
-33.5%
|
50,88
|
381 600
USD
|
|
2024-03-11 |
2024-03-07 |
V
Vente
|
Fust Matthew K
Administrateur non-exécutif
|
2 145
-8.8%
50,85
109 073
USD
|
2 145
-8.8%
|
50,85
|
109 073
USD
|
|
2024-03-11 |
2024-03-07 |
V
Vente
|
Fust Matthew K
Administrateur non-exécutif
|
2 550
-9.4%
50,89
129 770
USD
|
2 550
-9.4%
|
50,89
|
129 770
USD
|
|
2024-03-05 |
2024-03-01 |
VP
Vente planifiée
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
Dirigeant
|
3 756
-5.3%
53,76
201 923
USD
|
3 756
-5.3%
|
53,76
|
201 923
USD
|
|
2024-03-05 |
2024-03-01 |
V
Vente
|
Pinion John Richard
See Remarks
Dirigeant
|
4 173
-4.5%
53,76
224 340
USD
|
4 173
-4.5%
|
53,76
|
224 340
USD
|
|
2024-03-05 |
2024-03-01 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
341
-0.8%
53,76
18 332
USD
|
341
-0.8%
|
53,76
|
18 332
USD
|
|
2024-03-05 |
2024-03-01 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
1 011
-0.4%
53,76
54 351
USD
|
1 011
-0.4%
|
53,76
|
54 351
USD
|
|
2024-03-05 |
2024-03-01 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
4 768
-6.6%
53,76
256 328
USD
|
4 768
-6.6%
|
53,76
|
256 328
USD
|
|
2024-03-05 |
2024-03-01 |
VP
Vente planifiée
|
Crombez Eric
EVP and Chief Medical Officer
Dirigeant
|
1 238
-2.5%
53,76
66 555
USD
|
1 238
-2.5%
|
53,76
|
66 555
USD
|
|
2024-02-08 |
2024-02-07 |
VP
Vente planifiée
|
KAKKIS EMIL D
President & CEO
Administrateur exécutif
|
30 000
-5.3%
45,00
1 350 000
USD
|
30 000
-5.3%
|
45,00
|
1 350 000
USD
|
|
2024-01-02 |
2023-12-29 |
VP
Vente planifiée
|
KAKKIS EMIL D
President & CEO
Administrateur exécutif
|
30 000
-5.0%
47,87
1 436 100
USD
|
30 000
-5.0%
|
47,87
|
1 436 100
USD
|
|
2023-10-24 |
2023-10-23 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
39 878
-13.9%
32,78
1 307 201
USD
|
39 878
-13.9%
|
32,78
|
1 307 201
USD
|
|
2023-10-23 |
2023-10-19 |
VP
Vente planifiée
|
KAKKIS EMIL D
President & CEO
Administrateur exécutif
|
47 853
-7.4%
33,52
1 604 033
USD
|
47 853
-7.4%
|
33,52
|
1 604 033
USD
|
|
2023-09-11 |
2023-09-07 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
163
-0.7%
38,34
6 249
USD
|
163
-0.7%
|
38,34
|
6 249
USD
|
|
2023-09-11 |
2023-09-07 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
2 000
-7.8%
41,00
82 000
USD
|
2 000
-7.8%
|
41,00
|
82 000
USD
|
|
2023-09-06 |
2023-09-05 |
V
Vente
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
6 000
-10.5%
37,96
227 760
USD
|
6 000
-10.5%
|
37,96
|
227 760
USD
|
|
2023-09-06 |
2023-09-01 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
87
-0.4%
38,23
3 326
USD
|
87
-0.4%
|
38,23
|
3 326
USD
|
|
2023-09-06 |
2023-09-01 |
VP
Vente planifiée
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
883
-3.6%
37,04
32 706
USD
|
883
-3.6%
|
37,04
|
32 706
USD
|
|
2023-06-21 |
2023-06-19 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
305
-0.5%
48,20
14 701
USD
|
305
-0.5%
|
48,20
|
14 701
USD
|
|
2023-06-09 |
2023-06-08 |
VP
Vente planifiée
|
Sanders Corazon (Corsee) D.
Administrateur non-exécutif
|
1 485
-13.4%
51,65
76 700
USD
|
1 485
-13.4%
|
51,65
|
76 700
USD
|
|
2023-05-19 |
2023-05-18 |
VP
Vente planifiée
|
Pinion John Richard
See Remarks
Dirigeant
|
2 012
-2.6%
50,00
100 600
USD
|
2 012
-2.6%
|
50,00
|
100 600
USD
|
|
2023-05-05 |
2023-05-04 |
VP
Vente planifiée
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
Dirigeant
|
4 378
-7.8%
45,00
197 010
USD
|
4 378
-7.8%
|
45,00
|
197 010
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Bedrosian Camille L
EVP and Chief Medical Officer
Dirigeant
|
3 881
-7.7%
45,25
175 615
USD
|
3 881
-7.7%
|
45,25
|
175 615
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Pinion John Richard
See Remarks
Dirigeant
|
3 755
-4.5%
45,26
169 951
USD
|
3 755
-4.5%
|
45,26
|
169 951
USD
|
|
2023-03-03 |
2023-03-01 |
VP
Vente planifiée
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
Dirigeant
|
3 161
-5.3%
45,25
143 035
USD
|
3 161
-5.3%
|
45,25
|
143 035
USD
|
|
2023-03-03 |
2023-03-01 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
3 664
-6.0%
45,25
165 796
USD
|
3 664
-6.0%
|
45,25
|
165 796
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Huang Dennis Karl
See Remarks
Dirigeant
|
389
-0.5%
45,65
17 758
USD
|
389
-0.5%
|
45,65
|
17 758
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
100
-0.4%
45,65
4 565
USD
|
100
-0.4%
|
45,65
|
4 565
USD
|
|
2023-03-03 |
2023-03-01 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
1 968
-0.8%
45,27
89 091
USD
|
1 968
-0.8%
|
45,27
|
89 091
USD
|
|
2023-03-02 |
2023-02-28 |
VP
Vente planifiée
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
639
-3.9%
43,40
27 733
USD
|
639
-3.9%
|
43,40
|
27 733
USD
|
|
2023-01-03 |
2022-12-30 |
VP
Vente planifiée
|
KAKKIS EMIL D
President & CEO
Administrateur exécutif
|
19 582
-3.5%
45,57
892 352
USD
|
19 582
-3.5%
|
45,57
|
892 352
USD
|
|
2022-12-22 |
2022-12-21 |
VP
Vente planifiée
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
2 031
-11.1%
43,96
89 283
USD
|
2 031
-11.1%
|
43,96
|
89 283
USD
|
|
2022-10-17 |
2022-10-14 |
VP
Vente planifiée
|
Dier Mardi
CFO & Executive Vice President
Dirigeant
|
1 629
-2.4%
40,16
65 421
USD
|
1 629
-2.4%
|
40,16
|
65 421
USD
|
|
2022-10-14 |
2022-10-12 |
V
Vente
|
Dier Mardi
CFO & Executive Vice President
Dirigeant
|
3 484
-4.9%
38,22
133 158
USD
|
3 484
-4.9%
|
38,22
|
133 158
USD
|
|
2022-06-22 |
2022-06-19 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
295
-0.8%
54,78
16 160
USD
|
295
-0.8%
|
54,78
|
16 160
USD
|
|
2022-04-19 |
2022-04-16 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
132
-0.8%
84,55
11 161
USD
|
132
-0.8%
|
84,55
|
11 161
USD
|
|
2022-03-15 |
2022-03-11 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
10 281
-4.3%
67,01
688 930
USD
|
10 281
-4.3%
|
67,01
|
688 930
USD
|
|
2022-03-08 |
2022-03-07 |
V
Vente
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
Dirigeant
|
5 140
-13.0%
62,95
323 563
USD
|
5 140
-13.0%
|
62,95
|
323 563
USD
|
|
2022-03-03 |
2022-03-03 |
VP
Vente planifiée
|
Dier Mardi
CFO & Executive Vice President
Dirigeant
|
420
-0.8%
64,55
27 111
USD
|
420
-0.8%
|
64,55
|
27 111
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
843
-6.0%
66,62
56 161
USD
|
843
-6.0%
|
66,62
|
56 161
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Parschauer Karah Herdman
EVP and Chief Legal Officer
Dirigeant
|
2 886
-10.2%
66,62
192 265
USD
|
2 886
-10.2%
|
66,62
|
192 265
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Pinion John Richard
See Remarks
Dirigeant
|
4 498
-9.0%
66,62
299 657
USD
|
4 498
-9.0%
|
66,62
|
299 657
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Dier Mardi
CFO & Executive Vice President
Dirigeant
|
534
-1.4%
66,62
35 575
USD
|
534
-1.4%
|
66,62
|
35 575
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
2 713
-10.8%
66,62
180 740
USD
|
2 713
-10.8%
|
66,62
|
180 740
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Huang Dennis Karl
See Remarks
Dirigeant
|
3 234
-8.1%
66,62
215 449
USD
|
3 234
-8.1%
|
66,62
|
215 449
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
2 374
-1.1%
66,62
158 156
USD
|
2 374
-1.1%
|
66,62
|
158 156
USD
|
|
2022-03-03 |
2022-03-01 |
V
Vente
|
Bedrosian Camille L
EVP and Chief Medical Officer
Dirigeant
|
2 821
-7.7%
66,62
187 935
USD
|
2 821
-7.7%
|
66,62
|
187 935
USD
|
|
2022-02-01 |
2022-01-30 |
V
Vente
|
Bedrosian Camille L
EVP and Chief Medical Officer
Dirigeant
|
1 657
-4.3%
66,30
109 859
USD
|
1 657
-4.3%
|
66,30
|
109 859
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
303
-1.2%
81,14
24 585
USD
|
303
-1.2%
|
81,14
|
24 585
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Huang Dennis Karl
EVP & Chief Tech Ops Officer
Dirigeant
|
358
-0.9%
81,14
29 048
USD
|
358
-0.9%
|
81,14
|
29 048
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Parschauer Karah Herdman
EVP and General Counsel
Dirigeant
|
310
-1.1%
81,14
25 153
USD
|
310
-1.1%
|
81,14
|
25 153
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Pinion John Richard
See Remarks
Dirigeant
|
358
-0.7%
81,14
29 048
USD
|
358
-0.7%
|
81,14
|
29 048
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Bedrosian Camille L
EVP and Chief Medical Officer
Dirigeant
|
359
-0.9%
81,14
29 129
USD
|
359
-0.9%
|
81,14
|
29 129
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Kassberg Thomas Richard
CBO & EVP
Dirigeant
|
286
-0.1%
81,14
23 206
USD
|
286
-0.1%
|
81,14
|
23 206
USD
|
|
2021-10-18 |
2021-10-14 |
V
Vente
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
140
-1.0%
81,14
11 360
USD
|
140
-1.0%
|
81,14
|
11 360
USD
|
|
2021-10-14 |
2021-10-14 |
VP
Vente planifiée
|
Dier Mardi
CFO & Executive Vice President
Dirigeant
|
3 261
-7.8%
81,16
264 663
USD
|
3 261
-7.8%
|
81,16
|
264 663
USD
|
|
2021-10-14 |
2021-10-12 |
V
Vente
|
Dier Mardi
CFO & Executive Vice President
Dirigeant
|
3 477
-7.6%
82,79
287 861
USD
|
3 477
-7.6%
|
82,79
|
287 861
USD
|
|
2021-07-08 |
2021-07-06 |
V
Vente
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
375
-1.5%
91,53
34 324
USD
|
375
-1.5%
|
91,53
|
34 324
USD
|
|
2021-06-23 |
2021-06-21 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
572
-2.2%
94,96
54 317
USD
|
572
-2.2%
|
94,96
|
54 317
USD
|
|
2021-06-23 |
2021-06-19 |
V
Vente
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
437
-1.6%
94,63
41 353
USD
|
437
-1.6%
|
94,63
|
41 353
USD
|
|
2021-05-10 |
2021-05-07 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
393
-1.4%
113,67
44 672
USD
|
393
-1.4%
|
113,67
|
44 672
USD
|
|
2021-05-10 |
2021-05-06 |
VP
Vente planifiée
|
Pinion John Richard
See Remarks
Dirigeant
|
363
-0.7%
113,69
41 269
USD
|
363
-0.7%
|
113,69
|
41 269
USD
|
|
2021-05-10 |
2021-05-06 |
VP
Vente planifiée
|
Parschauer Karah Herdman
EVP and General Counsel
Dirigeant
|
313
-1.0%
113,67
35 579
USD
|
313
-1.0%
|
113,67
|
35 579
USD
|
|
2021-05-10 |
2021-05-06 |
V
Vente
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
307
-1.1%
113,68
34 900
USD
|
307
-1.1%
|
113,68
|
34 900
USD
|
|
2021-05-10 |
2021-05-06 |
VP
Vente planifiée
|
Huang Dennis Karl
EVP & Chief Tech Ops Officer
Dirigeant
|
363
-0.9%
113,68
41 266
USD
|
363
-0.9%
|
113,68
|
41 266
USD
|
|
2021-05-10 |
2021-05-06 |
VP
Vente planifiée
|
Huizenga Theodore Alan
SVP, Chief Accounting Officer
Dirigeant
|
142
-0.9%
113,67
16 141
USD
|
142
-0.9%
|
113,67
|
16 141
USD
|
|
2021-05-10 |
2021-05-06 |
V
Vente
|
Bedrosian Camille L
EVP and Chief Medical Officer
Dirigeant
|
364
-0.9%
113,67
41 376
USD
|
364
-0.9%
|
113,67
|
41 376
USD
|
|
2021-04-21 |
2021-04-20 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
396
-1.4%
104,28
41 295
USD
|
396
-1.4%
|
104,28
|
41 295
USD
|
|
2021-04-19 |
2021-04-15 |
V
Vente
|
Bedrosian Camille L
EVP and Chief Medical Officer
Dirigeant
|
5 000
-11.3%
109,09
545 450
USD
|
5 000
-11.3%
|
109,09
|
545 450
USD
|
|
2021-03-09 |
2021-03-08 |
V
Vente
|
Huizenga Theodore Alan
SVP, Controller and PAO
Dirigeant
|
3 000
-18.1%
120,69
362 070
USD
|
3 000
-18.1%
|
120,69
|
362 070
USD
|
|
2021-03-03 |
2021-03-02 |
VP
Vente planifiée
|
Harris Erik
EVP & Chief Commercial Officer
Dirigeant
|
707
-2.5%
138,16
97 679
USD
|
707
-2.5%
|
138,16
|
97 679
USD
|
|
2021-03-03 |
2021-03-01 |
V
Vente
|
Huizenga Theodore Alan
SVP, Controller and PAO
Dirigeant
|
732
-4.2%
138,17
101 140
USD
|
732
-4.2%
|
138,17
|
101 140
USD
|
|